title: Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?
authors.affiliation: Program in Emerging Viral Diseases, Duke-NUS Graduate Medical School, Singapore ; Viral Hepatitis Unit, Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (AStar), Singapore.
authors.forename: Antonio
authors.initials: A
authors.lastname: Bertoletti
authors.affiliation: Molecular Microbiology and Immunology Department, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America.
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Gehring
mesh_terms: D056704:Adaptive Immunity / Q000502:physiology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D006515:Hepatitis B virus / Q000187:drug effects / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D007167:Immunotherapy / Q000379:methods*; D008099:Liver / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents